Identity
- Trade Name
- EB0330X - Letto Theorema EUDAMED
- Device Name
- Letto Theorema elettrico ad altezza variabile EUDAMED
- Model / Reference
- EB0330X EUDAMED
Identifiers
- Primary DI / UDI-DI
- 08052530400616 EUDAMED
- Basic UDI-DI
- 805253040EB0330XLK EUDAMED
- EMDN Code
- V08060101 HOSPITAL/HOME CARE ELECTRIC MEDICAL BEDS EUDAMED
Classification
- Device Class
- Class I EUDAMED
- Market of Registration
- Italy EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Category: Basic electric hospital bed
EB0330X - Letto Theorema by Givas Srl — Class I — MDR — listed in EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Basic electric hospital bed.
- Electrical Hospital Bed — PARAMOUNT BED CO., LTD. · Class I
- 48 Advantage Bed — SIZEWISE RENTALS, L.L.C. · Class II
- MATRIX U24 — IMO - Indústrias Metalúrgicas, S.A. · Class I
- Electric Hospital Bed — HEBEI DANSONG MEDICAL EQUIPMENT CO.,LTD · Class I
- BED G RECOM PLUS L/TUBE 105X206 DARKGREY — TECNIMOEM CARE S.L. · Class I
- MC Healthcare — Span-America Medical Systems, Inc. · Class II
- Electric Bed — Jiangmen Jia Mei Medical Products Co.,Ltd. · Class I
- Electrical Hospital Bed — PARAMOUNT BED CO., LTD. · Class I
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 805253040EB0330XLK | Class I | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Givas Srl
- EUDAMED SRN
- IT-MF-000025753
Sources (1)
- EUDAMED c454bd4b-1866-40ed-b5ad-9c2bfeafda24 61 fields · synced Jun 18, 2026